GlassScriptPhysician profile
Arvind R Krishnan
NPI 1982136933
$6,196.43
in general payments reported to CMS, 2019-2025
36 companies · $1,456 in 2025
The $1,456 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $482 · 2020: $122 · 2021: $21.70 · 2022: $1,013 · 2023: $2,025 · 2024: $1,077 · 2025: $1,456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,301 · Education: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,300.75 |
| Education | $256.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $1,257.17 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $787.11 | 2019-2024 | Ams 700 Cxr Rte Kit, Rezum Generator |
| Janssen Biotech, INC. | $739.55 | 2022-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $729.44 | 2022-2025 | Xtandi, Myrbetriq, Veozah |
| Progenics Pharmaceuticals, INC. | $203.13 | 2023-2025 | Pylarify |
| Coloplast Corp | $202.01 | 2022-2024 | Titan |
| Medtronic USA, INC. | $176.01 | 2019 | |
| Endo Pharmaceuticals INC. | $172.47 | 2023-2024 | Xiaflex, Aveed, Edex |
| Bayer Healthcare Pharmaceuticals INC. | $153.10 | 2022-2025 | |
| Endo USA, INC. | $148.91 | 2024-2025 | Xiaflex, Aveed, Edex |
| Axonics, INC. | $148.61 | 2023 | Bulkamid, Axonics |
| Baxter Healthcare | $146.70 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $129.59 | 2022-2025 | Lynparza, Keytruda |
| Abbvie INC. | $128.36 | 2022-2025 | |
| Travere Therapeutics, INC. | $122.32 | 2020 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $112.49 | 2025 | Tornado |
| Dendreon Pharmaceuticals LLC | $109.42 | 2022-2023 | Provenge |
| Photocure INC | $88.59 | 2024-2025 | Cysview |
| Ferring Pharmaceuticals INC. | $88.36 | 2025 | Adstiladrin |
| Tolmar, INC. | $54.57 | 2023 | |
| Sun Pharmaceutical Industries INC. | $53.98 | 2023-2024 | Yonsa |
| Accord Healthcare, INC. | $52.99 | 2022-2024 | |
| Urovant Sciences INC | $52.86 | 2022 | |
| Urogen Pharma, INC. | $46.07 | 2023-2025 | Jelmyto |
| Immunitybio, INC. | $39.49 | 2025 | |
| Myovant Sciences INC. | $39.38 | 2022 | |
| Teleflex LLC | $35.84 | 2023-2025 | Urolift, Barrigel |
| Srs Medical Systems, INC. | $28.65 | 2024-2025 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Hollister Incorporated | $25.32 | 2023 | Onli, Vapro Pocket |
| Lantheus Medical Imaging, INC. | $24.43 | 2024 | |
| Alnylam Pharmaceuticals INC. | $20.15 | 2023 | Givlaari |
| Pfizer INC. | $17.51 | 2025 | |
| Verity Pharmaceuticals INC. | $17.23 | 2023 | Trelstar |
| Tolmar Pharmaceuticals, INC. | $15.83 | 2022 | |
| Acerus Pharmaceuticals Corporation | $14.56 | 2022 | |
| Laborie Medical Technologies Corp. | $14.23 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arvind Krishnan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.